Article Text

Download PDFPDF
Early surgery versus watchful waiting for asymptomatic severe aortic valve stenosis: a hot topic for the past 20 years
  1. Sylvestre Marechaux1,2,
  2. Christophe Tribouilloy2,3
  1. 1Cardiology Department, GCS-Groupement des hôpitaux de l'institut Catholique de Lille, Université Catholique de Lille, Lille, France
  2. 2INSERM U 1088, Université de Picardie, Amiens, France
  3. 3Cardiology Department, Centre Hospitalier Universitaire d'Amiens, Amiens, France
  1. Correspondence to Professor Christophe Tribouilloy, Department of Cardiology, Avenue René Laënnec, Amiens 80054, Cedex 1, France; tribouilloy.christophe{at}

Statistics from

Request Permissions

If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.

Severe aortic stenosis (AS) is currently defined as an aortic valve area (AVA) <1.0 cm2 and/or mean trans-aortic pressure gradient >40 mm Hg and/or peak aortic jet velocity (Vmax) >4 m/s. Only patients with severe AS associated with symptoms or left ventricular ejection fraction (LVEF) <50% present an European Society of Cardiology class I indication for aortic valve replacement (AVR),1 based on the findings of Ross's and Braunwald's landmark report showing a dramatic increase in mortality after symptom onset in patients with AS while ‘operative treatment was deemed to be the most common cause of sudden death in asymptomatic AS patients’. The annualised rate of sudden death is estimated to be around 1% per year in asymptomatic patients, which must be weighed up against the operative mortality of AVR (1%–3% in patients aged <70 years and 3%–8% in older patients). In addition, the native valve is usually replaced by a prosthetic valve, which is associated with specific life-threatening complications (thrombosis, endocarditis, need for reoperation). In contrast, it has been suggested that some patients with severe asymptomatic AS may be operated at an excessively advanced stage of the disease, at which myocardial impairment is at least partially irreversible, consequently resulting in a higher risk of mortality and heart failure (HF). This debate remains unresolved, as some experts suggest early surgery to spare the left ventricle (LV) and improve long-term survival, while others advocate AVR only after onset of symptoms.

The slowly progressive nature of AS combined with the relatively advanced age of the population affected by this disease predispose to under-reporting and/or underestimation of symptoms. Thus, a recent series based on cardiopulmonary exercise testing reported a 28% rate of ‘false asymptomatic AS patients’. Exercise …

View Full Text


  • Competing interests None declared.

  • Provenance and peer review Commissioned; internally peer reviewed.

Linked Articles